Downstream processing - Pharmaceutical Biotechnology: Concepts and Aapplications - page 174

Flickinger, M. 1999. The Encyclopedia of Bioprocess Technology . Wiley.
Frokjaer, S. 2000. Pharmaceutical Formulation Development of Peptides and Proteins . Taylor and Francis.
Grindley, J. and Ogden, J. 2000. Understanding Biopharmaceuticals. Manufacturing and Regulatory Issues .
Interpharm Press.
Harris, E. 2000. Protein Purifi cation Applications . Oxford University Press.
Merten, O.-W., Mattanovich, D., Lang, C., Larsson, G., Neubauer, P., Porro, D., Postma, P., Teixeira de Mattos, J.,
and Cole, J.A. Recombinant Protein Production with Prokaryotic and Eukaryotic Cells: A Comparative View
on Host Physiology ? Kluwer.
Janson, J. 1998. Protein Purifi cation . Wiley.
Oxender, D. and Post, L. 1999. Novel Therapeutics from Modern Biotechnology . Springer Verlag.
Roe, S. 2001. Protein Purifi cation Techniques . Oxford University Press.
Walsh, G. 2002. Proteins: Biochemistry and Biotechnology . Wiley.
Articles
Arakawa, T., Prestrelski, S.J., Kenney, W.C., and Carpenter, J.F. 2001. Factors effecting short-term and long-term
stabilities of proteins. Advanced Drug Delivery Reviews 46 , 307-326.
Bernard, A.R., Lusti-Narasimhan, M., Radford, K.M., Hale, R.S., Sebille, E., and Graber, P. 1996. Downstream
processing on insect cultures. Cytotechnology 20 (1-3), 239-257.
Cleland, J.L., Powell, M.F., and Shire, S.J. 1993. The development of s table protein formulations: a close look at
protein aggregation, deamidation and oxidation. Critical Reviews in Therapeutic Drug Carrier Systems 10 (4),
307-377.
Frokjaer, S. and Otzen, D. 2005. Protein drug stability: a formulation challenge. Nature Reviews Drug Discovery
4 , 298-306.
Hedhammar, M., Gräslund, T., and Hober, S. 2005. Protein engineering strategies for selective protein purifi ca-
tion. Chemical Engineering and Technology 28 , 1315-1325.
Keller, K., Friedmann, T., and Boxman, A. 2001. The bioseparation needs for tomorrow. Tren ds in Biotech nology
19 (11), 438- 441.
Lee, J. 2000. Biopharmaceutical formulation. Current Opinion in Biotechnology 11 (1), 81-84.
Nikolov, Z. and Woodard, S. 2004. Downstream processing of recombinant proteins from transgenic feedstock.
Current Opinion in Biotechnology 15 , 479-486.
Shire, S.J., Shahrokh, Z., and Liu J. 2004. Challenges in the development of high protein concentration formula-
tions. Journal of Pharmaceutical Sciences 93 , 1390-1402.
Wang, W. 2000. Lyophilizatin and development of solid protein pharmaceuticals. International Journal of Phar-
maceutics 203 (1-2), 1- 60.
Wei, W. 1999. Instability, stabilization and formulation of liquid protein pharmaceuticals. International Journal
of Pharmaceutics 185 (2), 129-188.